Australia markets open in 6 hours 50 minutes

Comera Life Sciences Holdings, Inc. (CMRA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0449+0.0029 (+6.90%)
As of 09:30AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0420
Open0.0449
Bid0.0000 x 2200
Ask0.0000 x 1800
Day's range0.0449 - 0.0449
52-week range0.0300 - 1.3800
Volume4,375
Avg. volume28,076
Market cap1.38M
Beta (5Y monthly)0.41
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

    WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a proprietary drug-delivery technology to improve patient access, safety, and convenience, today announced the closing of a bridge financing with a syndicate of investors. Following the closing, the investors exercised a purchase option to acquire all of the outstanding common stock of the Company not already held by the investors to t

  • GlobeNewswire

    Comera Life Sciences Announces Process Exploring Strategic Alternatives

    WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. As part of its process, Comera is exploring the potential for an acquisition, company sale, merger, divestiture of assets, licensing,

  • GlobeNewswire

    Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

    Dorothy Clarke Dorothy Clarke WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of directors. “Dorothy’s extensive experience will help Comera continue to deliver on its mission of delivering transformative solutions that have the potential to revolutionize the way